Sun Chengqing, Li Jianjun, Liu Xiaoyan, Zhang Zhi, Qiu Tao, Hu Haiyang, Wang You, Fu Gengfeng
School of Public Health, Nanjing Medical University, Nanjing, People's Republic of China.
Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, People's Republic of China.
AIDS Res Ther. 2021 Dec 11;18(1):96. doi: 10.1186/s12981-021-00415-2.
Late presentation to HIV/AIDS care presents serious health concerns, like increased transmission and high healthcare costs, increased mortality, early development of opportunistic infection, increased risk of antiretroviral therapy drug resistance. Despite the effort to contain the HIV/AIDS epidemic, LP has remained an impediment to individual immune reconstitution and public health.
This review aimed to estimate the prevalence and determine the factors associated with late presentation to HIV/AIDS care.
We searched PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Wanfang, and Weipu database for articles published from 2010 to 2020. We utilized I statistics and Q-test to estimate heterogeneity between studies. Random-effects meta-analysis models were used to calculate the aggregate odds ratio of late presentation to HIV/AIDS care.
Of 9563 titles and abstracts retrieved, 189 were identified as potentially eligible and 39 fulfilled the inclusion criteria. The pooled prevalence of late presentation to HIV/AIDS care was 43.26%. The major risk factors were patients ≥ 50 years old (OR = 2.19, 95% CI: 1.85-2.58; I = 97.44%), married (OR = 1.50, 95% CI: 1.35-1.68; I = 96.58%), with heterosexual contact as risk factor for infection (OR = 1.91, 95% CI: 1.73-2.11; I = 90.74%) and diagnosed in medical institutions (OR = 2.35,95% CI: 2.11-2.62; I = 96.05%). In middle or low HIV prevalence areas, patients ≥ 50 years old (P = 0.01), married (P < 0.01) and diagnosed in medical institutions (P = 0.01) were more likely to be presented late than in high prevalence areas. From 2016-2020, the OR of patients who were married and diagnosed in medical facilities were significantly lower than before (P < 0.01).
Patients ≥ 50 years old, married, with heterosexual contact as risk factor for infection, and diagnosed in medical institutions were risk factors of LP. Gender had no significant relationship with LP. In middle or low prevalence areas, patients who were ≥ 50 years old, married, and diagnosed in medical institutions were more likely to be presented late than in other areas. Married patients and those diagnosed in medical institutions after 2015 have a lower risk of LP than before.
晚期接受艾滋病病毒/艾滋病治疗存在严重的健康问题,如传播增加、医疗成本高昂、死亡率上升、机会性感染早期发生、抗逆转录病毒治疗耐药风险增加。尽管努力控制艾滋病病毒/艾滋病疫情,但晚期就诊仍是个体免疫重建和公共卫生的一个障碍。
本综述旨在估计晚期接受艾滋病病毒/艾滋病治疗的患病率,并确定与之相关的因素。
我们检索了PubMed、科学网、中国知网、万方数据库和维普数据库,查找2010年至2020年发表的文章。我们使用I统计量和Q检验来估计研究之间的异质性。采用随机效应荟萃分析模型计算晚期接受艾滋病病毒/艾滋病治疗的综合比值比。
在检索到的9563篇标题和摘要中,189篇被确定为可能符合条件,39篇符合纳入标准。晚期接受艾滋病病毒/艾滋病治疗的合并患病率为43.26%。主要危险因素为年龄≥50岁的患者(比值比=2.19,95%置信区间:1.85-2.58;I=97.44%)、已婚(比值比=1.50,95%置信区间:1.35-1.68;I=96.58%)、以异性接触为感染危险因素(比值比=1.91,95%置信区间:1.73-2.11;I=90.74%)以及在医疗机构确诊(比值比=2.35,95%置信区间:2.11-2.62;I=96.05%)。在艾滋病病毒低流行或中等流行地区,年龄≥50岁的患者(P=0.01)、已婚患者(P<0.01)以及在医疗机构确诊的患者(P=0.01)比在高流行地区更有可能晚期就诊。2016年至2020年期间,已婚且在医疗机构确诊的患者的比值比显著低于之前(P<0.01)。
年龄≥50岁、已婚以异性接触为感染危险因素且在医疗机构确诊的患者是晚期就诊的危险因素。性别与晚期就诊无显著关系。在低流行或中等流行地区,年龄≥50岁、已婚且在医疗机构确诊的患者比其他地区更有可能晚期就诊。已婚患者以及2015年后在医疗机构确诊的患者晚期就诊风险低于之前。